跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Ping Hsing Tsai
, Mong Lien Wang
, De Ming Yang
, Kung How Liang
, Shih Jie Chou
,
Shih Hwa Chiou
,
Ta Hsien Lin
,
Chin Tien Wang
, Tai Jay Chang
*
*
此作品的通信作者
藥理學研究所
醫學系生物化學科
臨床醫學研究所
研究成果
:
Article
›
同行評審
29
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Upstream Open Reading Frame (uORF)
100%
Spike Protein
100%
Genetic Variance
100%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
100%
United States
50%
Ribonucleic Acid
50%
ORF1ab
50%
Taiwan
33%
Japan
33%
China
33%
ORF3
33%
ORF6
33%
Asia
16%
Virus
16%
Australia
16%
South Korea
16%
Structural Proteins
16%
Sequence Alignment
16%
Influenza
16%
E Protein
16%
Genomic Analysis
16%
Multiple Sequence Alignment
16%
Multiple Sequences
16%
Human Will
16%
Transmembrane
16%
Genome Replication
16%
GenBank
16%
ClustalW
16%
COVID-19
16%
N Protein
16%
Genome Alignment
16%
Wuhan China
16%
Global Initiatives
16%
Severe Pneumonia
16%
Nucleocapsid (N) Protein
16%
M Protein
16%
Geneious
16%
Spike Glycoprotein
16%
Viral Envelope
16%
Ncbi
16%
Alignment Analysis
16%
Genebank
16%
Pandemic Crisis
16%
ORF10
16%
Spike Region
16%
Genomic Alignment
16%
Mutant Strain
16%
Scale Sequence
16%
Current Report
16%
Proteins Form
16%
Biochemistry, Genetics and Molecular Biology
Open Reading Frame
100%
SARS Coronavirus
100%
Genomics
100%
Spike Protein
100%
Sequence Alignment
33%
RNA
33%
Spike
33%
G Protein
33%
Glycoprotein
16%
Structural Protein
16%
Virus Nucleocapsid
16%
GenBank
16%
Coronavirinae
16%
Vitronectin
16%
Virus Envelope
16%
RNA Virus
16%
Immunology and Microbiology
Open Reading Frame
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike Protein
100%
Spike
33%
Sequence Alignment
33%
Ribonucleic Acid
33%
Glycoprotein
16%
Influenza
16%
RNA Virus
16%
Viral Envelope
16%
Virus Nucleocapsid
16%
GenBank
16%
COVID-19
16%
Structural Protein
16%
Replication
16%